Orion Portfolio Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
Orion Portfolio Solutions's PPH Position: Q4 2022 in Review
Orion Portfolio Solutions reduced its VanEck Pharmaceutical ETF (PPH) stake by 3.6% in Q4 2022, selling an estimated $139K and leaving 49,940 shares worth $3.88M. The position accounts for 0.14% of the portfolio, ranked #109.
Orion Portfolio Solutions first reported a position in PPH in Q4 2019 and has held it in 13 quarters since. The position peaked at $11M in Q4 2019. 113 funds tracked by Wall St. Rank hold PPH as of Q4 2022.
- Orion Portfolio Solutions held 49,940 shares of VanEck Pharmaceutical ETF worth $3.88M as of Q4 2022.
- Orion Portfolio Solutions sold 1,886 VanEck Pharmaceutical ETF shares in Q4 2022, an estimated $139K.
- VanEck Pharmaceutical ETF made up 0.14% of Orion Portfolio Solutions's portfolio in Q4 2022, its #109 holding.
- Orion Portfolio Solutions first reported a position in VanEck Pharmaceutical ETF in Q4 2019 and has held it in 13 quarters since.
- Orion Portfolio Solutions's VanEck Pharmaceutical ETF position peaked at $11M in Q4 2019.
- 113 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2022.
Based on Orion Portfolio Solutions's 13F filing for Q4 2022, filed 8 Feb 2023.